March Biosciences Revenue and Competitors
Employee Data
- March Biosciences has 15 Employees.
- March Biosciences grew their employee count by 114% last year.
March Biosciences's People
Name | Title | Email/Phone |
---|
March Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 13 | 44% | N/A | N/A |
#2 | $14.9M | 73 | -8% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 5 | -37% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 51 | 31% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $1.6M | 9 | 13% | N/A | N/A |
#10 | $16.3M | 80 | -9% | N/A | N/A |
What Is March Biosciences?
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient care in the most challenging hematological malignancies. March Bio's lead asset is at the end of Phase I trials for T-cell malignancies, diseases with a dismal prognosis that is currently unaddressed by CAR-T and targeted therapy technologies. The company's pipeline is designed to expand on these early successes to more broadly impact other high-challenge cancers.
keywords:N/AN/A
Total Funding
15
Number of Employees
N/A
Revenue (est)
114%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.1M | 15 | -12% | $750M |
#2 | $2.4M | 15 | N/A | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $3.3M | 15 | 0% | N/A |
#5 | $1.3M | 15 | 0% | N/A |